Response to bevacizumab after treatment with aflibercept in eyes with neovascular AMD

Waizel, Maria; Rickmann, Annekatrin; Blanke, Bjoern R.; Wolf, Katharina; Kazerounian, Sara; Szurman, Peter

dc.contributor.author	Szurman, Peter
dc.contributor.author	Blanke, Björn Rudolf
dc.date.accessioned	2018-11-27T09:27:11Z
dc.date.available	2018-11-27T09:27:11Z
dc.date.issued	2016
dc.identifier.issn	1724-6016
dc.identifier.uri	http://hdl.handle.net/10900/85002
dc.language.iso	en	de_DE
dc.publisher	Wichtig Publishing	de_DE
dc.relation.uri	http://dx.doi.org/10.5301/ejo.5000781	de_DE
dc.rights	info:eu-repo/semantics/closedAccess
dc.subject.ddc	610	de_DE
dc.title	Response to bevacizumab after treatment with aflibercept in eyes with neovascular AMD	de_DE
dc.type	Article	de_DE
utue.quellen.id	20180405102126_01264
utue.publikation.seiten	469-472	de_DE
utue.personen.roh	Waizel, Maria
utue.personen.roh	Rickmann, Annekatrin
utue.personen.roh	Blanke, Bjoern R.
utue.personen.roh	Wolf, Katharina
utue.personen.roh	Kazerounian, Sara
utue.personen.roh	Szurman, Peter
dcterms.isPartOf.ZSTitelID	European Journal of Ophthalmology	de_DE
dcterms.isPartOf.ZS-Issue	5	de_DE
dcterms.isPartOf.ZS-Volume	26	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE